The comparison between combination of candesartan-amlodipine and candesartan-furosemide on blood pressure in hypertensive patients with chronic kidney disease

Chronic renal disease is significantly increased by hypertension. Controlling blood pressure is critical in hypertensive individuals. Patients who have good blood pressure (BP) control can reduce morbidity and mortality. This study aimed to compare blood pressure reduction of candesartan-amlodipine...

Full description

Saved in:
Bibliographic Details
Main Authors: Dian Ayu Juwita (Author), Fitri Rachmaini (Author), Almahdy (Author), Rahmad Abdillah (Author), Yolanda Mayestika Wati (Author)
Format: Book
Published: Universitas Ahmad Dahlan, 2022-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e563e3fd7dbf4ce19c6f044db06a0f46
042 |a dc 
100 1 0 |a Dian Ayu Juwita  |e author 
700 1 0 |a Fitri Rachmaini  |e author 
700 1 0 |a Almahdy  |e author 
700 1 0 |a Rahmad Abdillah  |e author 
700 1 0 |a Yolanda Mayestika Wati  |e author 
245 0 0 |a The comparison between combination of candesartan-amlodipine and candesartan-furosemide on blood pressure in hypertensive patients with chronic kidney disease 
260 |b Universitas Ahmad Dahlan,   |c 2022-07-01T00:00:00Z. 
500 |a 10.12928/pharmaciana.v12i2.21491 
500 |a 2088-4559 
500 |a 2477-0256 
520 |a Chronic renal disease is significantly increased by hypertension. Controlling blood pressure is critical in hypertensive individuals. Patients who have good blood pressure (BP) control can reduce morbidity and mortality. This study aimed to compare blood pressure reduction of candesartan-amlodipine with the candesartan-furosemide combination in hypertensive patients with chronic renal disease. The study was conducted by a cohort study design. Retrieval of medical record data was carried out prospectively during the period February-April 2019. The blood pressure reduction was assessed by changes in mean systolic and mean diastolic blood pressure and mean diastolic blood pressure and was analyzed statistically with the SPSS program. A total of 54 patients met the inclusion criteria, consisting of 27 patients receiving candesartan-amlodipine combination and 27 patients receiving candesartan-furosemide combination therapy. The results of the sociodemographic characteristics patients were male 30 patients (55.6%), age 56-65 years 24 patients (44.4%), senior high school education level 31 patients (57.4%). Candesartan-amlodipine and candesartan-furosemide combinations both decreased blood pressure in patients. However, the result of the statistical analysis revealed that there was no significant difference in blood pressure decline. (p> 0.05) between the two combinations. 
546 |a EN 
690 |a blood pressure 
690 |a candesartan 
690 |a amlodipine 
690 |a furosemide 
690 |a hypertension 
690 |a ckd 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaciana, Vol 12, Iss 2, Pp 218-226 (2022) 
787 0 |n http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/21491/pdf_238 
787 0 |n https://doaj.org/toc/2088-4559 
787 0 |n https://doaj.org/toc/2477-0256 
856 4 1 |u https://doaj.org/article/e563e3fd7dbf4ce19c6f044db06a0f46  |z Connect to this object online.